Evidence map›Paper›PMID 36882343›Full record

ReviewSeminars in diagnostic pathology2023

AI in Pathology: What could possibly go wrong?

Keisuke Nakagawa, Lama Moukheiber, Leo A Celi, Malhar Patel, Faisal Mahmood, Dibson Gondim, Michael Hogarth, Richard Levenson

Abstract readReview
In one paragraph

Review in Seminars in diagnostic pathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. The patient matters: a roundtable discussion on pathology in the era of digitization and AI.Virchows Archiv : an international journal of pathology · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Artificial Intelligence in Histopathology.Journal of pharmacy & bioallied sciences · 2024
    Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Keisuke NakagawaUC Davis Health, Sacramento, CA.
Lama MoukheiberMassachusetts Institute of Technology, Cambridge, MA.
Leo A CeliMassachusetts Institute of Technology, Cambridge, MA.
Malhar PatelRhino Health, Boston, MA.
Faisal MahmoodBrigham and Women's Hospital, Boston, MA.
Dibson GondimUniversity of Louisville, Lousville, KY.
Michael HogarthUC San Diego, San Diego, CA.
Richard LevensonUC Davis Health, Sacramento, CA. Electronic address: rmlevenson@ucdavis.edu.

Funding

Breast core-needle diagnostics in LMICs via millifluidics and direct-to-digital imaging: development and validation in GhanaU01CA269191 · NCI · UNIVERSITY OF WASHINGTON · PI RICHARD M. LEVENSON, Eric J Seibel · 2023 to 2026
$2.4M
IMAT-ITCR Collaboration: Combining FIBI and topological data analysis: Synergistic approaches for tumor structural microenvironment explorationR33CA278544 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ICZKOWSKI, KENNETH A · 2023 to 2025
$988k
NCI NIH HHS R33 CA278544NCI NIH HHS U01 CA269191
6 · The paper itself

Abstract

The field of medicine is undergoing rapid digital transformation. Pathologists are now striving to digitize their data, workflows, and interpretations, assisted by the enabling development of whole-slide imaging. Going digital means that the analog process of human diagnosis can be augmented or even replaced by rapidly evolving AI approaches, which are just now entering into clinical practice. But with such progress comes challenges that reflect a variety of stressors, including the impact of unrepresentative training data with accompanying implicit bias, data privacy concerns, and fragility of algorithm performance. Beyond such core digital aspects, considerations arise related to difficulties presented by changing disease presentations, diagnostic approaches, and therapeutic options. While some tools such as data federation can help with broadening data diversity while preserving expertise and local control, they may not be the full answer to some of these issues. The impact of AI in pathology on the field's human practitioners is still very much unknown: installation of unconscious bias and deference to AI guidance need to be understood and addressed. If AI is widely adopted, it may remove many inefficiencies in daily practice and compensate for staff shortages. It may also cause practitioner deskilling, dethrilling, and burnout. We discuss the technological, clinical, legal, and sociological factors that will influence the adoption of AI in pathology, and its eventual impact for good or ill.

Indexed as

AlgorithmsPathologistsArtificial IntelligenceHumans

Identifiers

PMID36882343
PMCPMC13175311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.